The uterine manipulators market has seen considerable growth due to a variety of factors.
• There has been significant growth in the uterine manipulators market size over the recent years. It is anticipated to escalate from $0.39 billion in 2024 to an approximate value of $0.41 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.37%.
This progressive trend during the historic era can be credited to factors such as a surge in the elderly population, a rise in the frequency of hysterectomy operations, enhanced awareness related to women's health and immediate medical assistance, upward healthcare spending in advancing economies, and constant improvement in healthcare infrastructure.
The uterine manipulators market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for significant expansion in the uterine manipulators market over the coming years, with anticipations of growth to $0.52 billion by 2029, thanks to a compound annual growth rate (CAGR) of 6.11%.
This promising forecast is linked to a heightened awareness of the advantages of uterine manipulators, the growing need for fertility therapies, a surge in cervical cancer incidences, an increase in laparoscopic hysterectomies, and a greater understanding of gynecological health. Key trends projected for the forecast period include progressive advancements in uterine manipulator technology, the use of robotics and imaging technologies in gynecological surgeries, the application of AR technology in uterine manipulators, a move towards uterine preservation treatments and the technological incorporation for real-time data.
The increasing occurrences of conditions affecting the female reproductive system look set to drive the expansion of the uterine manipulators market. These gynecological ailments, including disorders affecting the uterus, ovaries, fallopian tubes, and cervix, are on the rise due to various factors such as changes in lifestyle, delayed childbirth, heightened stress, environmental pollutants, and an increasing prevalence of obesity. Uterine manipulators play a key role in providing precise access and maneuverability during minimally invasive medical procedures, thereby improving the treatment and diagnosis of gynecological conditions and enhancing patient outcomes. For example, the World Health Organization (WHO) - a Switzerland-based intergovernmental body - expressed in March 2023 that endometriosis is a condition affecting around 190 million women and girls of reproductive age globally. Similarly, the American Cancer Society, a non-profit organization situated in the United States, reported in February 2023 that about 13,960 new instances of invasive cervical cancer were expected to be diagnosed in 2023 and it was estimated that approximately 4,310 women would succumb to cervical cancer within this time frame. Consequently, the increasing prevalence of gynecological diseases is supporting the growth of the uterine manipulators market.
The uterine manipulators market covered in this report is segmented –
1) By Type: Uterine Injector, Mangeshikar, Clermont Ferrand, VECTEC, Other Types
2) By Application: Laparoscopic Surgeries, Hysteroscopic Surgeries, Fertility Treatments, Other Applications
3) By End-User: Specialty clinics, Hospitals, Ambulatory surgical centers
Subsegments:
1) By Uterine Injector: Single-Use Uterine Injectors, Reusable Uterine Injectors, Sterile Uterine Injectors
2) By Mangeshikar: Mangeshikar Type I, Mangeshikar Type II
3) By Clermont Ferrand: Clermont Ferrand Uterine Manipulator for Laparoscopic Surgery, Clermont Ferrand Uterine Manipulator For Hysteroscopic Procedures
4) By VECTEC: VECTEC Uterine Manipulator with Adjustable Length, VECTEC Uterine Manipulator With Rotational Features
5) By Other Types: Disposable Uterine Manipulators, Robotic-Assisted Uterine Manipulators, Electromechanical Uterine Manipulators
Leading firms in the uterine manipulators market are shifting their focus to the introduction of innovative products, for example, novel laparoscopic devices. These devices are created to increase accuracy, diminish the recovery period for patients, and elevate the overall results of surgeries. The new generation laparoscopic devices are specific surgical tools used in less intrusive procedures, helping surgeons carry out operations with minor incisions, improved visual aid, and accuracy. In one instance, Lagis Enterprise Co. Ltd., a medical device manufacturer based out of Taiwan, unveiled Balloon Trocar, Uterine Manipulator-Injector at the Arab Health event in January 2023. The Uterine Manipulator-Injector is a surgical tool that serves to both adjust the position of the uterus and instill fluids during gynecological procedures, thus lending superior visibility and control in less invasive surgeries. The balloon trocar, being a surgical tool, creates a regulated point of entry into the body during laparoscopic procedures, and comes with a balloon feature that ensures a tight seal and lowers the chances of injury to nearby tissues.
Major companies operating in the uterine manipulators market are include:
• Johnson & Johnson
• Medtronic plc
• Olympus Corporation
• CooperSurgical Inc.
• Karl Storz SE & Co. KG
• Conmed Corporation
• Richard Wolf GmbH
• Laborie Medical Technologies Corp.
• B. Braun Melsungen AG
• Aspen Surgical Products Inc.
• Peters Surgical India Private Limited
• LiNA Medical APS
• LSI Solutions Inc.
• MedGyn Products Inc.
• Purple Surgical
• Zhejiang Geyi Medical Instrument Co. Ltd.
• Advin Health Care
• IndoSurgicals Private Limited
• Cliniva Healthcare
• Girish Surgical Works
North America was the largest region in the uterine manipulators market in 2024. The regions covered in the uterine manipulators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.